On August 7, Jiangsu Hengrui Pharmaceuticals Co.,Ltd. responded to investor inquiries on its interactive platform, stating that secondary market stock price fluctuations are influenced by a combination of multiple factors. The company conducts share buybacks strictly in accordance with relevant regulations.

Jiangsu Hengrui Pharmaceuticals Co.,Ltd. is committed to developing its core business. By maintaining a solid operational foundation, the company aims to preserve its long-term value and ultimately reward shareholders with improved performance.